Cost-minimization analysis of sequential genetic testing versus targeted next-generation sequencing gene panels in patients with pheochromocytoma and paraganglioma.

doi:10.1080/07853890.2021.1956687

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Cost-minimization analysis of sequential genetic testing versus targeted next-generation sequencing gene panels in patients with pheochromocytoma and paraganglioma.

Annals of medicine - 1 Dec 2021

Pipitprapat Weenita, Pattanaprateep Oraluck, Iemwimangsa Nareenart, Sensorn Insee, Panthan Bhakbhoom, Jiaranai Poramate, Chantratita Wasun, Sorapipatcharoen Kinnaree, Poomthavorn Preamrudee, Mahachoklertwattana Pat, Sura Thanyachai, Tunteeratum Atchara, Srichan Kanoknan, Sriphrapradang Chutintorn

Abstract excerpt

INTRODUCTION: Pheochromocytomas and paragangliomas (PPGLs) are highly heritable tumours, with up to 40% of cases carrying germline variants. Current guidelines recommend genetic testing for all patients with PPGLs. Next-generation sequencing (NGS) enables accurate, fast, and inexpensive genetic testing. This study aimed to compare the costs related to PPGL genetic testing between the sequential testing using the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Gland Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Costs and Cost Analysis

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Germ-Line Mutation

Share to High-Throughput Nucleotide Sequencing

Share to Paraganglioma

Share to Pheochromocytoma

Source

Open in PubMed Open full text

Identifiers

PMID: 34309460
DOI: 10.1080/07853890.2021.1956687
PMCID: PMC8317928

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cost-minimization analysis of sequential genetic testing versus targeted next-generation sequencing gene panels in patients with pheochromocytoma and paraganglioma.PMID 34309460Read ↗

Next-generation sequencing for the diagnosis of hereditary pheochromocytoma and paraganglioma syndromesSemantic proximity Read ↗

PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics.Semantic proximity Read ↗

Diagnosis and Management of Hereditary Phaeochromocytoma and Paraganglioma.Semantic proximity Read ↗

Clinical exome next‑generation sequencing panel for hereditary pheochromocytoma and paraganglioma diagnosisSemantic proximity Read ↗

Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research ApproachesSemantic proximity Read ↗

Clinical Predictors for Germline Mutations in Head and Neck Paraganglioma Patients: Cost Reduction Strategy in Genetic Diagnostic Process as Fall-OutSemantic proximity Read ↗

Pheochromocytoma and paraganglioma: molecular testing and personalized medicine.Semantic proximity Read ↗

Germline Multigene Panel Testing in Japanese Patients with Pheochromocytoma and Paraganglioma: Technical Feasibility and Clinical Utility.Semantic proximity Read ↗

Targeted next-generation sequencing detects rare genetic events in pheochromocytoma and paragangliomaSemantic proximity Read ↗

A comprehensive next generation sequencing-based genetic testing strategy to improve diagnosis of inherited pheochromocytoma and paraganglioma.Semantic proximity Read ↗

Review of sequencing platforms and their applications in phaeochromocytoma and paragangliomas.Semantic proximity Read ↗

Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.